Lopinavir Terminated Phase 2 Trials for Tuberculosis Infection / Human Immunodeficiency Virus (HIV) Infections Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT01601626Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
NCT02116660Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
NCT00090779Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV